Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Forskolin: a potential antimetastatic agent.

K C Agarwal, R E Parks

    International Journal of Cancer
    |December 15, 1983
    PubMed
    Summary

    Forskolin, a natural compound, effectively inhibits cancer cell-induced platelet aggregation. This discovery suggests potential clinical value for forskolin in preventing cancer metastasis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Diagnosis and management options in malignant pleural effusions.

    Lung India : official organ of Indian Chest Society·2017
    Same author

    Penicillin Resistant Gonococci.

    Indian journal of dermatology, venereology and leprology·2017
    Same author

    Visualization of surface figure by the use of Zernike polynomials.

    Applied optics·2010
    Same author

    Test of a slow off-axis parabola at its center of curvature.

    Applied optics·2010
    Same author

    Mirror deflection on multiple axial supports.

    Applied optics·2010
    Same author

    Contoured support method of local optical figuring.

    Applied optics·2010

    Area of Science:

    • Pharmacology
    • Oncology
    • Biochemistry

    Background:

    • Forskolin is a diterpene derived from Coleus forskohlii.
    • It is known to be a potent inhibitor of platelet aggregation.
    • Cancer metastasis involves complex interactions, including platelet activation.

    Purpose of the Study:

    • To investigate the effects of forskolin on tumor-induced platelet aggregation.
    • To evaluate forskolin's efficacy in preventing pulmonary tumor colonization in a murine model.

    Main Methods:

    • Utilized B16-F10 murine melanoma cells, known for high lung metastatic potential.
    • Assessed inhibition of melanoma cell-induced human platelet aggregation by forskolin (2 microM).
    • Administered forskolin (82 micrograms/mouse) prior to B16-F10 cell injection in mice to measure lung tumor colonization reduction.

    Main Results:

    • Forskolin significantly inhibited melanoma cell-induced human platelet aggregation.
    • A single dose of forskolin reduced lung tumor colonization by over 70% in mice.
    • Consistent results were observed across three independent experiments.

    Conclusions:

    • Forskolin demonstrates potent anti-metastatic properties in preclinical models.
    • Its ability to inhibit platelet aggregation may contribute to its anti-metastatic effects.
    • Forskolin holds potential for clinical application in cancer metastasis prevention.

    Related Experiment Videos